Recent Updates
Recently added Catalysts
SINT Positive Sentiment Score: 75/100

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Key Takeaway: SINTX Technologies, Inc. announced preliminary unaudited financial results for Q4 and the full year of 2022, with revenues reported at approximately $770,000 and $1.6 million respectively. The company experienced growth throughout the year and attributed revenue increases to contracts in the biomedical field and contributions from a recent acquisition. Looking ahead, SINTX expects further revenue growth in 2023, especially in aerospace and energy markets, as it prepares to fully operationalize its Armor facility in Salt Lake City. However, these results are preliminary and subject to audits, which may lead to changes in the reported figures.

Market Sentiment Analysis

POSITIVE FACTORS

  • SINTX Technologies reported revenue growth in 2022, exceeding prior years.
  • Anticipation of new revenue sources in 2023 from aerospace and energy markets.
  • Successful contribution from a recent acquisition in Maryland.
  • The company’s facility in Salt Lake City is set to become fully operational shortly.

CONCERNS & RISKS

  • The reported financial results are preliminary and unaudited, subject to change.
  • Uncertainties in new product development could delay commercialization.
  • Competition may affect market acceptance of SINTX's products.

Full Press Release Details

Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update
LAKE CITY, Jan. 19, 2023 (GLOBE NEWSWIRE) - SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) ("SINTX"
or the "Company"), an original equipment manufacturer of advanced ceramics, announced today select preliminary unaudited
financial results for the fourth quarter and full year ended December 31, 2022. These results are subject to the completion of the Company's
year-end financial reporting processes, reviews, and audit.
unaudited estimated revenue was approximately $770k in Q4 2022 and $1.6 million for the year ended December 31, 2022. The Company continued
quarter-on-quarter revenue growth throughout 2022 and exceeded the annual revenue of any prior year since selling the spine business
contracts and grants in biomedical and technical ceramics fields made up $521k in Q4 2022 and $962k for the full year. Sources of commercial
revenue included products for aerospace, energy, dental, and spine markets totaling $248k in Q4 2022 and $602k for the full year. SINTX's
recent acquisition in Maryland also made a large contribution to the overall revenue result.
anticipates new revenue sources in 2023 via continued growth in the aerospace and energy markets. In addition, the Company expects the
Armor facility in Salt Lake City to be fully operational in Q1.
are very pleased to update our shareholders and other partners on our progress in 2022," said Dr. Sonny Bal, President and CEO
of SINTX. "The entire SINTX team worked very hard and executed against some significant opportunities. We are all very excited
for the future of SINTX."
SINTX Technologies, Inc.
Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and
technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products
have been implanted in humans since 2008. Over the past two years, SINTX has utilized strategic acquisitions and alliances to enter into
new markets. The Company has manufacturing facilities in Utah and Maryland.
more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com.
and Unaudited Nature of Reported Results
have not yet completed the preparation of our financial statements for the fourth quarter and full year ended 2022. Our revenue expectations
for the fourth quarter and full year ended 2022, are preliminary, unaudited and are subject to change based on the completion of ongoing
internal control, review, and audit procedures. As a result, these amounts may differ materially from the amounts that will be reflected
in the Company's consolidated financial statements for the year ended December 31, 2022. Accordingly, you should not place undue
reliance on this preliminary estimate.
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA)
that are subject to a number of risks and uncertainties, including the Company's anticipation of new revenue sources in 2023 via
continued growth in the aerospace and energy markets, and the Company's expectation regarding when the Armor facility in Salt Lake
City will be fully operational. These risks and uncertainties, many of which are beyond our control, include, among other things: our
products may not prove to be as effective as other products currently being commercialized or to be commercialized in the future by competitors;
risks inherent in manufacturing and scaling up to commercial quantities while maintaining quality controls; volatility in the price of
SINTX's common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize
such product(s); market acceptance of our products once commercialized; SINTX's ability to raise funding and other competitive
developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on
which they are made and reflect management's current estimates, projections, expectations, and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which
can be found in SINTX's Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission
(SEC) on March 25, 2022, and in SINTX's other filings with the SEC. SINTX undertakes no obligation to publicly revise or update
the forward-looking statements to reflect events or circumstances that arise after the date of this report.
or Media Inquiries for SINTX
Technologies 801.839.3502

Frequently Asked Questions

What was SINTX's Q4 2022 revenue estimate?

SINTX's estimated revenue for Q4 2022 was approximately $770,000.

How did SINTX's revenue for 2022 compare to previous years?

SINTX exceeded its annual revenue from any prior year since selling its spine business.

What contributed to SINTX's revenue in 2022?

Revenue was driven by biomedical contracts, grants, and products for various markets.

When is the Armor facility expected to be operational?

The Armor facility in Salt Lake City is expected to be fully operational in Q1 2023.

What are SINTX's expected revenue sources for 2023?

SINTX anticipates growth in the aerospace and energy markets to generate new revenue.

Last updated: Jan 19, 2023